Samsung to focus on its core amid rising uncertainties
the global operation of its semiconductor business, without elaborating.Meanwhile, Samsung's leadership is under pressure from the expanding prosecution investigation into Samsung BioLogics Co., a bio health care unit accused of accounting fraud.Last month, prosecutors indicted two vice presidents of Samsung Electronics on allegations of masterminding destruction of evidence related to Samsung BioLogics, putting a burden on the 51-year-old Lee, who is also awaiting the Supreme Court's ruling on his bribery case.Civic groups claimed the alleged accounting fiasco at BioLogics was ultimately intended to enhance the Samsung heir's control of the sprawling group by inflating Cheil Industries Inc.'s stake in Samsung BioLogics ahead of its merger with Samsung C&T Corp. in 2015.
--IANS ksc/prs